16,052
Total Claims
$2.9M
Drug Cost
1,304
Beneficiaries
$2,231
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+112%
Cost per patient vs peers
$2,231 vs $1,054 avg
+43%
Brand preference vs peers
18.7% vs 13.1% avg
Opioid Prescribing
0.1%
Opioid Rate
20
Opioid Claims
$68
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
81% generic
Brand: 3,006 claims · $2.5M
Generic: 13,046 claims · $397K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sacubitril/Valsartan | 1,412 | $1.2M |
| Apixaban | 778 | $747K |
| Rivaroxaban | 149 | $163K |
| Ranolazine | 918 | $110K |
| Dapagliflozin Propanediol | 65 | $85K |
| Dronedarone Hcl | 48 | $45K |
| Empagliflozin | 57 | $42K |
| Ticagrelor | 56 | $38K |
| Evolocumab | 39 | $38K |
| Icosapent Ethyl | 73 | $36K |
| Isosorbide Mononitrate | 1,020 | $22K |
| Prasugrel Hcl | 323 | $21K |
| Pitavastatin Calcium | 38 | $20K |
| Propafenone Hcl | 230 | $19K |
| Clopidogrel Bisulfate | 1,077 | $16K |
Prescribing Profile
78
Unique Drugs
$2.3M
Patient Profile
74
Avg Age
55%
Female
1.89
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About